EU Regulator Backs UniQure's Glybera As First Gene Therapy
Dutch biotech company uniQure's Glybera, a gene therapy treatment for a rare fat processing disorder, is poised to become the first such treatment approved for use in the western world after...To view the full article, register now.
Already a subscriber? Click here to view full article